Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …

Background Dabigatran, which is administered in a fixed dose and does not require
laboratory monitoring, may be suitable for extended treatment of venous thromboembolism …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce several
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …

Lead candidates from protein profiling of VTE patients' plasma offer a promising outlook in
developing low cost, confirmatory, point-of-care testing for VTE. Additionally, addressing the …

Background. Despite the fact that COVID-19 usually manifests with severe pneumonia, there
is a growing body of evidence that life-threatening multiorgan damage is caused by vascular …

BACKGROUND: Although the number of vascular surgeries performed is increasing, the
incidence of complications associated with this surgery has not improved and re-operations …

Введение. Сулодексид-это полимер, в структуру которого включены неразветвленные
полисахаридные цепи, образованные повторением определенной дисахаридной …

Dear Editor, The elaborate and precise review of Harry N. Magnani didactically
demonstrates the complex pathophysiological aspects of coronavirus disease 2019 (COVID …

Vascular disorder is prominent in COVID-19, mainly characterized by endothelial damage,
severe inflammation and thrombotic trend. We reviewed the data suggesting that …

Введение. Метаболический синдром (МС), являясь полиэтиологичным состоянием,
способствует потенциро-ванию рисков, ассоциированных с тромбоэмболическими и …